|
Real-time Estimate
Cboe BZX
17:43:28 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9490 USD | +0.16% |
|
-0.97% | -43.27% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
NYSE
LCTX 0.9515 $
+0.42%
557K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 0.9515USD | +0.42% | 557K $ | ||
CBOE
| LCTX | 0.9494USD | -0.64% | 14.48K $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 294.80ILa | -1.93% | 228K ILa | |
|
Deutsche Boerse AG
| BT3 | 0.8140EUR | -1.69% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.8330EUR | +0.60% | 0 € | |
|
Tradegate
| BT3 | 0.8420EUR | -0.94% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.8500EUR | +1.67% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 24/09/2026 | 25/09/2026 | 28/09/2026 | 29/09/2026 | 30/09/2026 | |
|---|---|---|---|---|---|
| Last | US$0.9478 | US$1.030 | US$0.9710 | US$0.9475 | US$0.9515 |
| Volume | 2,439,912 | 2,481,540 | 1,574,173 | 2,592,143 | 585,156 |
| Change | -0.93% | +8.67% | -5.73% | -2.42% | +0.16% |
| Opening | US$0.9519 | US$0.9500 | US$1.020 | US$0.9800 | US$0.9503 |
| High | US$0.9692 | US$1.040 | US$1.040 | US$0.9900 | US$0.9882 |
| Low | US$0.9101 | US$0.9419 | US$0.9600 | US$0.9203 | US$0.9472 |
Performance
| 1 day | +0.16% | ||
| 1 week | -0.97% | ||
| Current month | -13.87% | ||
| 1 month | -13.87% | ||
| 3 months | -27.68% | ||
| 6 months | -35.55% | ||
| Current year | -43.27% | ||
| 1 year | -43.94% | ||
| 3 years | -16.16% | ||
| 5 years | -62.40% | ||
| 10 years | -75.71% |
Volumes
marketsDaily volume
585,156
Estimated daily volume
1,248,988
Avg. Volume 20 sessions
1,632,191
Daily volume ratio
0.77
Avg. Volume 20 sessions USD
1,548,949.26
Record volume 1
23,661,485
Record volume 2
22,539,712
Record volume 3
17,430,494
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
239,629,822
Net sales (USD)
14,556,000
Number of employees
75
Sales / Employee (USD)
194,080
Free-Float
95.14%
Free-Float capitalization (USD)
227,983,775
Average Daily Capital Traded
0.65%
Indicators
Moving average 5 days
0.9706
Moving average 20 days
1.042
Moving average 50 days
1.074
Moving average 100 days
1.168
Price spread / (MMA5)
+2.28%
Price spread / (MMA20)
+9.78%
Price spread / (MMA50)
+13.18%
Price spread / (MMA100)
+23.03%
STIM
RSI 9 days
40.33
RSI 14 days
40.86
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -0.97% | -43.94% | -16.16% | 240M | |
| +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +81.33% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +36.79% | 48.85B | |
| +0.92% | +1.11% | +42.59% | +39.69% | 44.28B | |
| +1.46% | +8.68% | +343.88% | +692.09% | 43.83B | |
| +1.92% | +2.13% | +9.42% | +108.84% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| +0.56% | -2.37% | -19.78% | +355.38% | 25.25B | |
| Average | +1.20% | -0.46% | +48.34% | +146.13% | 39.37B | |
| Weighted average by Cap. | +1.39% | +0.62% | +63.58% | +155.02% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
8392650f123c3bcf1447b91deb0.GiyCo2P3sIX7M26rIEqKBDz5qjiGTimUyCnTcwUyM38.c3bu8wCU3byNRSL0SSX5b2qQy0nZfBj9oVO4PEZBfD5tTfHrKbqdyYJXDQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 17:32:41 | 0.9515 | 100 | 543,951 |
| 17:32:11 | 0.9515 | 100 | 543,851 |
| 17:32:09 | 0.9515 | 300 | 543,751 |
| 17:32:09 | 0.9515 | 300 | 543,451 |
| 17:32:09 | 0.9521 | 200 | 543,151 |
| 17:32:09 | 0.9515 | 100 | 542,951 |
| 17:32:09 | 0.9521 | 300 | 542,851 |
| 17:32:09 | 0.9501 | 1,000 | 542,551 |
| 17:32:01 | 0.9529 | 100 | 541,551 |
| 17:31:56 | 0.9515 | 300 | 541,451 |
Price Extremes
| 1 week | 0.91 |  | 1.04 |
| 1 month | 0.91 | | 1.16 |
| Current year | 0.91 | | 1.98 |
| 1 year | 0.91 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.97 |
Monthly variations
Annual variations
| 2026 | -43.26% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
